Analyst Consensus ?
ConsensusHold52 ratings
Bullish2344.2%
Neutral2853.9%
Bearish11.9%
FN2 Earnings Intelligence
Marriott International, Inc. analyst ratings
Marriott International, Inc. (MAR) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$394.75Previous close
$160Low
$332.42Average
$449High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Overweight | Overweight | Maintain | Oct 22, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Oct 21, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Oct 19, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Oct 19, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 16, 2026 |
| Truist Securities | Hold | Hold | Maintain | Sep 10, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 20, 2026 |
| Macquarie | Neutral | Neutral | Maintain | Aug 5, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Aug 4, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Aug 4, 2026 |
| Baird | Neutral | Neutral | Maintain | Aug 4, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 21, 2026 |
| Stifel | Hold | Hold | Maintain | Jul 17, 2026 |
| Bernstein | Outperform | Outperform | Maintain | May 15, 2026 |
| Susquehanna | Neutral | Neutral | Maintain | Apr 23, 2026 |
| Jefferies | Buy | Buy | Maintain | Feb 11, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Feb 11, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jan 15, 2026 |
| Argus Research | Buy | Buy | Maintain | Jan 16, 2025 |
| B of A Securities | Buy | Buy | Maintain | Oct 21, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Aug 1, 2024 |
| Credit Suisse | Hold | Hold | Maintain | Feb 16, 2023 |
| Redburn Partners | Sell | Sell | Maintain | Nov 30, 2022 |
| Berenberg | Buy | Hold | Upgrade | Sep 15, 2022 |
| Loop Capital | Hold | Hold | Maintain | Feb 16, 2022 |
| Gordon Haskett | Hold | Hold | Maintain | Jun 26, 2020 |
| Nomura Instinet | Buy | Buy | Maintain | Jun 23, 2020 |
| Nomura | Buy | Buy | Maintain | Jun 23, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | May 13, 2020 |
| RBC Capital | Sector Perform | Outperform | Downgrade | Mar 30, 2020 |
| CFRA | Hold | Hold | Maintain | Feb 28, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Feb 27, 2020 |
| Raymond James | Market Perform | Outperform | Downgrade | Jan 7, 2020 |
| Longbow Research | Neutral | Underperform | Upgrade | Jul 15, 2019 |
| Argus | Hold | Buy | Downgrade | Nov 20, 2018 |
| Cowen & Co. | Outperform | Outperform | Maintain | Oct 23, 2018 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Aug 30, 2017 |
| Guggenheim | Neutral | Neutral | Maintain | Apr 26, 2017 |
| MKM Partners | Buy | Neutral | Upgrade | Dec 5, 2016 |
| Canaccord Genuity | Buy | Buy | Maintain | Mar 23, 2016 |
| Telsey Advisory Group | Perform | Market Perform | Maintain | Jan 4, 2016 |
| Brean Capital | Hold | Hold | Maintain | Jun 25, 2015 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Feb 19, 2015 |
| FBR Capital | Outperform | Outperform | Maintain | Sep 9, 2014 |
| Bank of America | Buy | Buy | Maintain | Jan 13, 2014 |
| Oddo Securities | Neutral | Reduce | Upgrade | Jul 2, 2013 |
| ISI Group | Buy | Neutral | Upgrade | Jun 3, 2013 |
| Evercore Partners | Overweight | Overweight | Maintain | May 29, 2013 |
| Cantor Fitzgerald | Buy | Buy | Maintain | Jan 14, 2013 |
| McNicoll Lewis Vlak | Hold | Hold | Maintain | Oct 5, 2012 |
| Keefe, Bruyette & Woods | Market Perform | Outperform | Downgrade | Sep 26, 2012 |
| Keefe Bruyette & Woods | Market Perform | Outperform | Downgrade | Sep 26, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $394.75. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Analyst unavailable | $403 | $401.84 | +2.1% | Oct 22, 2026 |
| Wells Fargo | Trey Bowers | $426 | $388.05 | +7.9% | Oct 19, 2026 |
| Barclays | Brandt Montour | $363 | $385.71 | -8.0% | Oct 16, 2026 |
| Morgan Stanley | Stephen Grambling | $384 | $365.88 | -2.7% | Oct 12, 2026 |
| Truist Financial | Analyst unavailable | $360 | $332.84 | -8.8% | Sep 10, 2026 |
| UBS | Robin Farley | $395 | $359.95 | +0.1% | Aug 20, 2026 |
| Deutsche Bank | Analyst unavailable | $372 | $344.7 | -5.8% | Aug 4, 2026 |
| Robert W. Baird | Analyst unavailable | $393 | $346.83 | -0.4% | Aug 4, 2026 |
| Barclays | Brandt Montour | $348 | $346.83 | -11.8% | Aug 4, 2026 |
| BMO Capital | Analyst unavailable | $395 | $346.83 | +0.1% | Aug 3, 2026 |
| Stifel Nicolaus | Simon Yarmak | $343 | $345.78 | -13.1% | Aug 3, 2026 |
| Barclays | Analyst unavailable | $379 | $366.24 | -4.0% | Jul 20, 2026 |
| Wells Fargo | Analyst unavailable | $449 | $369.05 | +13.7% | Jul 16, 2026 |
| Bernstein | Analyst unavailable | $412 | $402.79 | +4.4% | Jun 15, 2026 |
| UBS | Analyst unavailable | $412 | $402.54 | +4.4% | Jun 15, 2026 |
| Bernstein | Analyst unavailable | $402 | $353.47 | +1.8% | May 15, 2026 |
| Morgan Stanley | Analyst unavailable | $353 | $354.77 | -10.6% | May 12, 2026 |
| Wells Fargo | Analyst unavailable | $446 | $355.54 | +13.0% | May 7, 2026 |
| Argus Research | John Staszak | $425 | $354.67 | +7.7% | May 7, 2026 |
| Deutsche Bank | Steven Pizzella | $376 | $354.87 | -4.7% | May 7, 2026 |
| Mizuho Securities | Analyst unavailable | $384 | $359.06 | -2.7% | May 7, 2026 |
| Robert W. Baird | Analyst unavailable | $386 | $359.06 | -2.2% | May 7, 2026 |
| Barclays | Analyst unavailable | $376 | $359.06 | -4.7% | May 7, 2026 |
| Evercore ISI | Analyst unavailable | $400 | $367.08 | +1.3% | Apr 24, 2026 |
| Susquehanna | Christopher Stathoulopoulos | $385 | $367.13 | -2.5% | Apr 23, 2026 |
| Barclays | Analyst unavailable | $372 | $363.74 | -5.8% | Apr 16, 2026 |
| Morgan Stanley | Analyst unavailable | $350 | $354.2 | -11.3% | Apr 10, 2026 |
| Truist Financial | Patrick Scholes | $350 | $366.67 | -11.3% | Feb 11, 2026 |
| Evercore ISI | Analyst unavailable | $385 | $366.5 | -2.5% | Feb 11, 2026 |
| Mizuho Securities | Ben Chaiken | $343 | $359.35 | -13.1% | Feb 11, 2026 |
| Goldman Sachs | Lizzie Dove | $398 | $358.15 | +0.8% | Feb 11, 2026 |
| Robert W. Baird | Analyst unavailable | $358 | $359.35 | -9.3% | Feb 11, 2026 |
| BMO Capital | Analyst unavailable | $400 | $359.35 | +1.3% | Feb 10, 2026 |
| Evercore ISI | Analyst unavailable | $350 | $320.56 | -11.3% | Jan 22, 2026 |
| Morgan Stanley | Stephen Grambling | $328 | $325.79 | -16.9% | Jan 16, 2026 |
| Barclays | Brandt Montour | $320 | $325.79 | -18.9% | Jan 16, 2026 |
| BMO Capital | Analyst unavailable | $370 | $324.91 | -6.3% | Jan 9, 2026 |
| Bernstein | Analyst unavailable | $369 | $314.95 | -6.5% | Jan 6, 2026 |
| Barclays | Analyst unavailable | $276 | $305.97 | -30.1% | Dec 17, 2025 |
| Goldman Sachs | Lizzie Dove | $345 | $298.78 | -12.6% | Dec 15, 2025 |
| Truist Financial | Patrick Scholes | $283 | $306.65 | -28.3% | Dec 4, 2025 |
| Goldman Sachs | Analyst unavailable | $288 | $281.86 | -27.0% | Nov 5, 2025 |
| Barclays | Brandt Montour | $274 | $272.24 | -30.6% | Nov 5, 2025 |
| Morgan Stanley | Stephen Grambling | $296 | $268.43 | -25.0% | Oct 22, 2025 |
| Barclays | Brandt Montour | $262 | $266.4 | -33.6% | Oct 3, 2025 |
| Argus Research | Analyst unavailable | $310 | $261.8 | -21.5% | Sep 18, 2025 |
| Bernstein | Analyst unavailable | $327 | $262.05 | -17.2% | Sep 17, 2025 |
| Truist Financial | Patrick Scholes | $278 | $265.07 | -29.6% | Sep 3, 2025 |
| Susquehanna | Christopher Stathoulopoulos | $280 | $273.23 | -29.1% | May 16, 2025 |
| Morgan Stanley | Analyst unavailable | $298 | $270.8 | -24.5% | Mar 4, 2025 |
| Evercore ISI | Duane Pfennigwerth | $330 | $290.75 | -16.4% | Feb 4, 2025 |
| Wells Fargo | Daniel Politzer | $285 | $290.75 | -27.8% | Feb 4, 2025 |
| Robert W. Baird | Michael Bellisario | $285 | $290.46 | -27.8% | Feb 3, 2025 |
| BMO Capital | Ari Klein | $265 | $259.66 | -32.9% | Nov 5, 2024 |
| Robert W. Baird | Michael Bellisario | $264 | $259.53 | -33.1% | Nov 5, 2024 |
| Mizuho Securities | Ben Chaiken | $246 | $259.66 | -37.7% | Nov 5, 2024 |
| Goldman Sachs | Lizzie Dove | $280 | $259.66 | -29.1% | Nov 5, 2024 |
| BMO Capital | Ari Klein | $255 | $264.97 | -35.4% | Oct 22, 2024 |
| Robert W. Baird | Michael Bellisario | $258 | $262.57 | -34.6% | Oct 17, 2024 |
| Bank of America Securities | Shaun Kelley | $275 | $253.04 | -30.3% | Sep 27, 2024 |
| Goldman Sachs | Lizzie Dove | $267 | $235.61 | -32.4% | Sep 18, 2024 |
| Bernstein | Richard Clarke | $262 | $231.37 | -33.6% | Aug 29, 2024 |
| Wells Fargo | Daniel Politzer | $238 | $216.12 | -39.7% | Aug 1, 2024 |
| Barclays | Brandt Montour | $240 | $227.3 | -39.2% | Aug 1, 2024 |
| Mizuho Securities | Ben Chaiken | $260 | $237.41 | -34.1% | Apr 23, 2024 |
| Mizuho Securities | Ben Chaiken | $263 | $252.11 | -33.4% | Mar 25, 2024 |
| Morgan Stanley | Stephen W Grambling | $225 | $191.62 | -43.0% | Sep 26, 2023 |
| Jefferies | Analyst unavailable | $184 | $174.96 | -53.4% | Feb 3, 2023 |
| Truist Financial | Analyst unavailable | $205 | $161.44 | -48.1% | Nov 15, 2022 |
| Barclays | Brandt Montour | $170 | $164.07 | -56.9% | Aug 15, 2022 |
| Argus Research | John Staszak | $203 | $154.02 | -48.6% | May 19, 2022 |
| BMO Capital | Ari Klein | $183 | $178.19 | -53.6% | May 5, 2022 |
| Stifel Nicolaus | Simon Yarmak | $180 | $179.38 | -54.4% | May 4, 2022 |
| Morgan Stanley | Analyst unavailable | $182 | $176.28 | -53.9% | May 2, 2022 |
| Truist Financial | Patrick Scholes | $182 | $174.92 | -53.9% | Feb 20, 2022 |
| Morgan Stanley | Thomas Allen | $172 | $183.26 | -56.4% | Feb 16, 2022 |
| Wells Fargo | Dori Kesten | $199 | $181.2 | -49.6% | Feb 15, 2022 |
| Cowen & Co. | Kevin Kopelman | $180 | $156.53 | -54.4% | Dec 7, 2021 |
| Evercore ISI | Steve Sakwa | $160 | $155.02 | -59.5% | Oct 19, 2021 |
Track every rating change on MAR the moment it posts. Free to start.
Start freeGet the MAR recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.